
Ticaheal 90mg Tablet
Marketer
Xenon Pharmaceuticals
Salt Composition
Ticagrelor (90mg)
Overview Ticaheal 90mg Tablet
CardioGuard 90mg tablets are antiplatelet agents, preventing harmful blood clot formation within blood vessels. This action mitigates the risk of heart attack or stroke in individuals with cardiac conditions. CardioGuard 90mg is also indicated for patients recovering from a recent heart attack, experiencing unstable angina, or post-stent placement. It helps prevent recurrent cardiac events, including further heart attacks, strokes, and stent thrombosis. Concurrent use with aspirin, another antiplatelet medication, is typically prescribed. CardioGuard 90mg can be administered with or without food, consistently at the same time daily. Continued use is vital, even during symptom-free periods; discontinuation increases the risk of cardiovascular events. The most frequent adverse effect is increased bleeding tendency, potentially prolonging bleeding time from injuries. While typically mild and self-resolving, persistent or excessive bleeding should be reported. Some patients experience mild dyspnea, usually resolving with continued therapy; worsening or persistent dyspnea warrants medical attention. CardioGuard 90mg is contraindicated in patients with active bleeding (e.g., stomach ulcers, intracranial hemorrhage) or liver disease. Prior to initiation, disclose any pre-existing medical conditions to your physician.
Uses of Ticaheal 90mg Tablet
Avoiding heart attacks and strokes
Major Benefits of Ticaheal 90mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ticaheal 90mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Ticaheal 90mg Tablet:
- Bleeding
- Breathlessness
How to use Ticaheal 90mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 90mg Ticaheal Tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
How Ticaheal 90mg Tablet works:
Aggrenox 90mg tablets are prescribed to inhibit platelet aggregation. Their mechanism of action prevents platelet clumping, reducing the risk of dangerous thrombus development. Consequently, the likelihood of a cardiac event or cerebrovascular accident is diminished.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Ticaheal 90mg Tablets requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Ticaheal 90mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Data on Ticaheal 90mg Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Ticaheal 90mg tablets.
KidneySAFE IF PRESCRIBED
Ticaheal 90mg tablets are considered safe for individuals with kidney impairment; no dosage alteration is advised. Data regarding Ticaheal 90mg tablet use in patients undergoing renal dialysis is currently limited.
LiverCAUTION
Patients with liver impairment should exercise caution when using Ticaheal 90mg tablets; dosage modification may be necessary. Consultation with a physician is advised. Ticaheal 90mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Ticaheal 90mg Tablet :
Should you forget to take a Ticaheal 90mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ticaheal 90mg Tablet
Label | Value |
---|---|
Chemical Category | Triazolopyrimidine derivatives |
Developing Habits | No. |
Treatment Category | KINSHIP |
Action Class | ADP receptor antagonists (P2Y12 inhibitors) |